Purdue Pharma, Sackler families boost contribution in opioid settlement to $7.4 billion
(NEW YORK) -- The company and once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation.The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end the costliest corporate bankruptcy resulting from the U.S. opioid crisis.Purdue, under the leadership of the Sackler families, […]